AAAAAA

   
Results: 1-17 |
Results: 17
ASSESSMENT OF CURRENT NATIONAL CHOLESTEROL EDUCATION-PROGRAM GUIDELINES FOR TOTAL CHOLESTEROL, TRIGLYCERIDE, HDL-CHOLESTEROL, AND LDL-CHOLESTEROL MEASUREMENTS
Authors: CAUDILL SP COOPER GR SMITH SJ MYERS GL
Citation: Sp. Caudill et al., ASSESSMENT OF CURRENT NATIONAL CHOLESTEROL EDUCATION-PROGRAM GUIDELINES FOR TOTAL CHOLESTEROL, TRIGLYCERIDE, HDL-CHOLESTEROL, AND LDL-CHOLESTEROL MEASUREMENTS, Clinical chemistry, 44(8), 1998, pp. 1650-1658
ADEQUACY OF NCEP RECOMMENDATIONS FOR TOTAL CHOLESTEROL, TRIGLYCERIDES, HDLC, AND LDLC MEASUREMENTS
Authors: CAUDILL SP SMITH SJ COOPER GR MYERS GL
Citation: Sp. Caudill et al., ADEQUACY OF NCEP RECOMMENDATIONS FOR TOTAL CHOLESTEROL, TRIGLYCERIDES, HDLC, AND LDLC MEASUREMENTS, Clinical chemistry, 44(5), 1998, pp. 1063-1064
CITATION-CLASSICS IN LIPID MEASUREMENT AND APPLICATIONS
Authors: GOTTO AM COOPER GR
Citation: Am. Gotto et Gr. Cooper, CITATION-CLASSICS IN LIPID MEASUREMENT AND APPLICATIONS, Clinical chemistry, 44(11), 1998, pp. 2234-2237
NEURONAL NITRIC-OXIDE SYNTHASE IS REFRACTORY TO MECHANISM-BASED INACTIVATION IN GH(3) PITUITARY-CELLS
Authors: COOPER GR BARR A WOLFF DJ
Citation: Gr. Cooper et al., NEURONAL NITRIC-OXIDE SYNTHASE IS REFRACTORY TO MECHANISM-BASED INACTIVATION IN GH(3) PITUITARY-CELLS, Archives of biochemistry and biophysics (Print), 357(2), 1998, pp. 195-206
ANALYSIS OF THE ENDOPLASMIC RETICULAR CA2-ANTITRYPSIN PROCESSING AND TRANSPORT COMPETENCE( REQUIREMENT FOR ALPHA(1))
Authors: COOPER GR BROSTROM CO BROSTROM MA
Citation: Gr. Cooper et al., ANALYSIS OF THE ENDOPLASMIC RETICULAR CA2-ANTITRYPSIN PROCESSING AND TRANSPORT COMPETENCE( REQUIREMENT FOR ALPHA(1)), Biochemical journal, 325, 1997, pp. 601-608
INDIVIDUAL VS LABORATORY VARIATION IN BLOOD LIPID VALUES - UPDATING THE LITERATURE - REPLY
Authors: COOPER GR
Citation: Gr. Cooper, INDIVIDUAL VS LABORATORY VARIATION IN BLOOD LIPID VALUES - UPDATING THE LITERATURE - REPLY, JAMA, the journal of the American Medical Association, 278(6), 1997, pp. 478-478
MULTIPLE RISK FACTOR INTERVENTION TRIAL - RISK FACTOR CHANGES AND MORTALITY RESULTS (REPRINTED FROM JAMA, VOL 248, PG 1465-1477, 1982)
Authors: PAUL O ARNOLD CB MANDRIOTA R AMES RP EISENBACH JR BOHN E THOMAS HE KANNEL WB ROTONDO R CONNORS J BRAND FN SMITH LK PRISCO MT GREENE P KEZDI P STANLEY EL BLACK WL ERNST FA CASE EJ BENTLEY V COVERT D LUCIUS M PARIS F SEMMETT R SKOTKO L CHRISTAKIS G BURR JM GERACE TA WILCOX ME BRAMSON D BENEZRA J WEDDLE J KAYE J PADRON M RAUTAHARJU PM WOLF H BENFARI RC MCINTYRE KM DANIELSON E OCKENE J KOUSCHHOWARD D BALDWIN AD WILD JB GREENLICK M GROVER J LAMB S BAILEY J DYER J BROKOP B STEVENS V BAILEY G HOLMES W PICKERING JE ALLAIRE J DUFFY EL FELLON D FEINSTEIN B HUTCHINS D RUBEL G COOPER GR BAYSE DD MILLER DT HAINLINE A KUCHMAK M WIEBE DA WINN CL TAYLOR L BOTERO BL GILL JB LASSER NL HYMOWITZ N MEZEY KC MUNVES B PARELL E BURGIO S LASSER V JOHNSON B JEFFREY S RICE E STAMLER J MOSS D PERSKY V ROBINSON E VANHORN L SHANNON K MEYERS D COHEN L MORGAN J GRUNDMANN G VESTAL TD HUANG B BERKSON DM LAUGER G GRUJIC S OBRADOVIC D PARDO E DUA S MCGOWAN S BILLINGS J HULLEY SB SMITH WM SYME SL COHEN R DZVONIK L ROOS L KAHN M WIDDOWSON GM WILLIAMS GZ KUEHNEMAN ML SCHOENBERGER JA SCHOENENBERGER JC SHEKELLE RB NERI GS DOLECEK T BETZ E SKWERES L OPPENHEIMER F GERNHOFER N HARDY GG MCGILL E HALL Y WRIGHT NH KOPEL SA SUCKERMAN KR SCHORIN M SIMON N COHEN JD BUNKERS E RONCHETTO B GRODSKY E FRESSOLA A DANIELGENTRY J TREIMAN R SULLIVAN W SCHNAPER HW HUGHES GH OBERMAN A HILL CC ALLEN R BRAGG C STOKES S JOHNSON P BORHANI NO SUGARS C KIRKPATRICK K LEE M DEBOURELANDO S LABAW F TURNERTUCKER J SHERWIN RW SEXTON MS CUSACK NE DEBARROS QTF DISCHINGER PC SPIZLER JF HEINER JD PILKINGTON MB SCANLON BL GRIMM RH MITTELMARK M CROW RS BLACKBURN H JACOBS D RAINS D MCDONALD M LENZ K PRINEAS RJ CROW RC BUZZARD IM GRAMBSCH PV WENZ J KJELSBERG MO BARTSCH GE NEATON JD AUS BM BENDICKSON J BROSTE SK CONNETT JE DUCHENE AG DURKIN DA GORDER DL GRANDITS GA HULTGREN DH KNICKERBOCKER A RASMUSSEN WL SVENDSEN KH WILLE L KULLER LH MCDONALD R CAGGIULA A FALVOGERARD L MEILAHN E MILAS NC RUSSELL R HORBIAK J ALMAN M SOUTHWICK K MOYER R GAHAGAN E GIESE WK MARTIN JF KEITH JA HARRISON HH MATHIS DE BROWN CK FISHMAN E WAMPLER L NEWMARK G ROSENFIELD F SIDDIQUI S SAVAGE W BRADFORD A INSULL W FARQUHAR JW JENKINS CD RAPAPORT E THOMPSON DJ TYROLER HA WILLIS PW FRIEDEWALD WT ZUKEL W DOYLE JT BURCHELL HB YU PN WILLIS PW FURBERG CD CUTLER JA ZUKEL WJ PASSAMANI ER KAELBER CT FARRAND ME TILLOTSON JL VERTER JI WU MC GORDON T HALPERIN M MCGEE DL BLASZKOWSKI TP EBERLEIN KA HARRIS CE DERN PL FRIEDMAN LM MAY GS VARGOSKO AJ
Citation: O. Paul et al., MULTIPLE RISK FACTOR INTERVENTION TRIAL - RISK FACTOR CHANGES AND MORTALITY RESULTS (REPRINTED FROM JAMA, VOL 248, PG 1465-1477, 1982), JAMA, the journal of the American Medical Association, 277(7), 1997, pp. 582-594
EXTRACTING METEOROLOGICAL DATA FROM PROJECTILE TRAJECTORY
Authors: COOPER GR FANSLER KS OSKAY V
Citation: Gr. Cooper et al., EXTRACTING METEOROLOGICAL DATA FROM PROJECTILE TRAJECTORY, Journal of spacecraft and rockets, 34(6), 1997, pp. 769-773
POINT - STATUS OF LIPID AND LIPOPROTEIN STANDARDIZATION
Authors: MCNAMARA JR LEARY ET CERIOTTI F BOERSMACOBBAERT CM COLE TG HASSEMER DJ NAKAMURA M PACKARD CJ SECCOMBE DW KIMBERLY MM MYERS GL COOPER GR
Citation: Jr. Mcnamara et al., POINT - STATUS OF LIPID AND LIPOPROTEIN STANDARDIZATION, Clinical chemistry, 43(8), 1997, pp. 1306-1310
ISOTOPE-DILUTION MASS-SPECTROMETRIC QUANTIFICATION OF SPECIFIC PROTEINS - MODEL APPLICATION WITH APOLIPOPROTEIN-A-I
Authors: BARR JR MAGGIO VL PATTERSON DG COOPER GR HENDERSON LO TURNER WE SMITH SJ HANNON WH NEEDHAM LL SAMPSON EJ
Citation: Jr. Barr et al., ISOTOPE-DILUTION MASS-SPECTROMETRIC QUANTIFICATION OF SPECIFIC PROTEINS - MODEL APPLICATION WITH APOLIPOPROTEIN-A-I, Clinical chemistry, 42(10), 1996, pp. 1676-1682
CALCIUM-DEPENDENT SITES OF ALPHA(1)-ANTITRYPSIN PROCESSING IN HEPG2 CELLS
Authors: COOPER GR BROSTROM CO BROSTROM MA
Citation: Gr. Cooper et al., CALCIUM-DEPENDENT SITES OF ALPHA(1)-ANTITRYPSIN PROCESSING IN HEPG2 CELLS, Molecular biology of the cell, 6, 1995, pp. 380-380
FRIEDEWALD FORMULA - REPLY
Authors: COOPER GR
Citation: Gr. Cooper, FRIEDEWALD FORMULA - REPLY, Clinical chemistry, 41(5), 1995, pp. 761-761
A RANDOMIZED TRIAL OF INTRAVENOUS HEPARIN IN CONJUNCTION WITH ANISTREPLASE (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX) IN ACUTE MYOCARDIAL-INFARCTION - THE DUKE-UNIVERSITY CLINICAL CARDIOLOGY STUDY (DUCCS) .1.
Authors: OCONNOR CM MEESE R CARNEY R SMITH J CONN E BURKS J HARTMAN C ROARK S SHADOFF N HEARD M MITTLER B COLLINS G NAVETTA F LEIMBERGER J LEE K CALIFF RM SANFORD CF DICK DM RANDALL R KUMMERFELD K MURPHY G LEBOEUF R SPENCER S SMITH JE MACKRELL J ANDERSON GP DUGAN TM BUETKOFER JA HEIBEL RH MCCLELLAN JR BLAKE JI HENRY P CONN E BERGLUND RK HUNT NC WRIGHT K PARKER S HOBACK JW MCWILLIAMS C BURKS J CALDER JR KEATING EC KIRBY J HARTMAN CW ASHBY CC DICKINSON WA BARTEL AG CALL TD KENERSON JG ROBBINS JA STCLAIR JW GRIFFIN JG MILLER EC OLD WD COMNINAKI K ROARK S COOPER GR SILVERSTEIN BV DILLON MG MARQUIS N SHADOFF N RAMO B GOSS JE RAFF GL LEATHERMAN GF BLAKE K HEIMGARTNER K BROWN A CARLSON EB HEARD ME ROGERS G PRIVETTE DC OSEROFF A DENTON S BREWER P MCKOWAN M MITTLER B WARREN K HORTON C COLLINS GJ BRODERICK GM COYNE E FELDMAN B ZEMAN H LOWRY D MILLER C HANGER K KMONICEK JM GRIEBEL M WILLIAMS B HETTLEMAN B FRIEDMAN B GREENBERG M ROLETT E ROBB J CATHERWOOD E ROKOWSKI R DUFFY C TORKELSON A NILES N PLEHN J JAMES D HOLZBERGER P CARLSON C MORIARITY C HASSAPOYANNES C NELSON W SAUNDERS DE HOPKINS CB KHOURY N SAENZ A NELSON W KHOURY L HENDERSON J BURKE F HICKS J KLINE M BERBIN M PEREZ J VILLASENOR H GARCIA JG GARZA A LILLY D CARTER W WARREN S VAUGHAN NA MCCOWAN R MCCORMICK S NOLAN S AYCOCK GR PICKENS WS DOTY WD ROGERS EW TRANTHAM JL RILEY CP WILCOX T TRAHEY T TAYLOR J SCHNEIDER R ORIHUELA L RICHTER SE MARTIN T GOETZ K EATHERTON R SAN G PRYOR WW KELLER J CIUFFO AA TAYLOR JB NYE GC PARKER JP LIPSKIS DJ STINE RA GOLDBERG MJ KLEVAN T HERRE JM BERNSTEIN R DANIELSON B WAGNER B WILLIAMS B BRAMLET D HOCHE J MCIVOR ME HECKMARTINEZ C GURBEL P PERPALL A ZISKIND A STAFFORD JL COLEGROVE P LEMON C WEFALD FC SMUCKER ML HOWARD P SARNET W SCHERB D KIL D OCONNOR CM CALIFF RM BERDAN L RENDALL D ALLEN T LUCAS KD TCHENG J WAGNER G LEE K WOODLIEF L LEIMBERGER J ROBERTS G KARNASH S MELTON J HUGULEY GS MARK DB GRANGER C OHMAN EM CALIFF RM LEE KL MAROKO P DALY R SALTZMAN M
Citation: Cm. Oconnor et al., A RANDOMIZED TRIAL OF INTRAVENOUS HEPARIN IN CONJUNCTION WITH ANISTREPLASE (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX) IN ACUTE MYOCARDIAL-INFARCTION - THE DUKE-UNIVERSITY CLINICAL CARDIOLOGY STUDY (DUCCS) .1., Journal of the American College of Cardiology, 23(1), 1994, pp. 11-18
TRADITIONAL LIPOPROTEIN PROFILE - CLINICAL UTILITY, PERFORMANCE REQUIREMENTS, AND STANDARDIZATION
Authors: MYERS GL COOPER GR SAMPSON EJ
Citation: Gl. Myers et al., TRADITIONAL LIPOPROTEIN PROFILE - CLINICAL UTILITY, PERFORMANCE REQUIREMENTS, AND STANDARDIZATION, Atherosclerosis, 108, 1994, pp. 190000157-190000169
METHOD-DEPENDENT VARIATIONS IN THE STABILITY OF APOLIPOPROTEIN-B IN ASTABILIZED LIQUID REFERENCE MATERIAL
Authors: MEI JV POWELL MK HENDERSON LO SMITH SJ COOPER GR MARCOVINA SM HANNON WH
Citation: Jv. Mei et al., METHOD-DEPENDENT VARIATIONS IN THE STABILITY OF APOLIPOPROTEIN-B IN ASTABILIZED LIQUID REFERENCE MATERIAL, Clinical chemistry, 40(5), 1994, pp. 716-722
ESTIMATING AND MINIMIZING EFFECTS OF BIOLOGIC SOURCES OF VARIATION BYRELATIVE RANGE WHEN MEASURING THE MEAN OF SERUM-LIPIDS AND LIPOPROTEINS
Authors: COOPER GR SMITH SJ MYERS GL SAMPSON EJ MAGID E
Citation: Gr. Cooper et al., ESTIMATING AND MINIMIZING EFFECTS OF BIOLOGIC SOURCES OF VARIATION BYRELATIVE RANGE WHEN MEASURING THE MEAN OF SERUM-LIPIDS AND LIPOPROTEINS, Clinical chemistry, 40(2), 1994, pp. 227-232
BIOLOGICAL VARIABILITY IN CONCENTRATIONS OF SERUM-LIPIDS - SOURCES OFVARIATION AMONG RESULTS FROM PUBLISHED STUDIES AND COMPOSITE PREDICTED VALUES
Authors: SMITH SJ COOPER GR MYERS GL SAMPSON EJ
Citation: Sj. Smith et al., BIOLOGICAL VARIABILITY IN CONCENTRATIONS OF SERUM-LIPIDS - SOURCES OFVARIATION AMONG RESULTS FROM PUBLISHED STUDIES AND COMPOSITE PREDICTED VALUES, Clinical chemistry, 39(6), 1993, pp. 1012-1022
Risultati: 1-17 |